ChemoCentryx Inc (CCXI)
NASDAQ · Financial Services
ChemoCentryx Inc EBITDA 2018–2021
ChemoCentryx Inc annual/quarterly ebitda history and growth rate from 2018 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- ChemoCentryx Inc ebitda for the quarter ending March 31, 2026 was -373673, a 98.99% decrease year-over-year.
- ChemoCentryx Inc ebitda for the twelve months ending March 31, 2026 was -67.5 M.
- ChemoCentryx Inc annual ebitda for 2021 was -125.9 M, a 142.55% increase from 2020.
- ChemoCentryx Inc annual ebitda for 2020 was -51.9 M, a 0.42% increase from 2019.
- ChemoCentryx Inc annual ebitda for 2019 was -51.7 M, a 42.69% increase from 2018.
- ChemoCentryx Inc annual ebitda for 2018 was -36.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ChemoCentryx Inc EBITDA — FAQ
ChemoCentryx Inc (CCXI) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CCXI's ebitda history?
The chart and table above show ChemoCentryx Inc's ebitda by year and by quarter, including the growth rate.